KeyMed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New Drug Application (the "sNDA") of ...

Discover how a newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.

Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental ...

CNW/ - Pharmascience Canada is proud to announce the launch of  Pr  pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal ...

The most specific treatment for allergic rhinitis is immunotherapy. This involves repeated injections of a tiny amount of allergen, with the aim of desensitising your immune system. This type of ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Acarizax (12 ...

The treatment, known as 12 SQ-HDM SLIT, will help with the allergy which can be debilitating and cause facial swelling, ...

Allergic rhinitis is a very common condition often termed as hay fever, which affects millions of people globally. This ...

The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

Rhinitis and pharmacological agents used for treatment are considered factors that could alter the rate and extent of absorption of drugs administered by the nasal route. The purpose of this study ...

This product has a broader label than other INS products: the package insert indication specifies treatment of symptoms of seasonal and perennial allergic rhinitis, rather than focusing ...